V Miller, A CozziLepri, K Hertogs, - PowerPoint PPT Presentation

1 / 11
About This Presentation
Title:

V Miller, A CozziLepri, K Hertogs,

Description:

... response to mega-HAART regimen in patients from the Frankfurt HIV Cohort ... The Frankfurt HIV Cohort consists of all patients attending the clinic who have ... – PowerPoint PPT presentation

Number of Views:30
Avg rating:3.0/5.0
Slides: 12
Provided by: fda
Learn more at: http://www.fda.gov
Category:

less

Transcript and Presenter's Notes

Title: V Miller, A CozziLepri, K Hertogs,


1
Association between phenotypic resistance and
virologic response to mega-HAART regimen in
patients from the Frankfurt HIV Cohort
  • V Miller, A Cozzi-Lepri, K Hertogs,
  • P Gute, B Larder, S Bloor,
  • C Rottmann, AN Phillips, S Staszewski

2
Introduction
  • The Frankfurt HIV Cohort consists of all patients
    attending the clinic who have presented at least
    once since Jan 1, 1995
  • data pertaining to antiretroviral history, immune
    status, HIV-1 viral load, HIV-associated clinical
    events and demographics are collected
    prospectively
  • patients with multiple treatment failures were
    treated with salvage regimen consisting of 6 or
    more antiretroviral drugs
  • phenotypic resistance tests were performed from
    stored plasma samples

3
Patients Methods
  • 50 patients met the definition criteria and the
    DAP requirements
  • viral load Amplicor
  • resistance Antivirogram (recombinant virus based
    phenotypic assay)
  • virologic failure gt 400 copies/week 24 window
  • statistical analysis as described per DAP

4
Study Population Baseline characteristics
  • Characteristic Median Range
  • HIV RNA (log10 copies/ml) 5.52 3.40 -
    6.70
  • CD4 cell count (cells/mm3) 95 2 - 587
  • Time on HAART (months) 18.3 1.7-53.5

5
Summary of previous ART
6
Susceptibility Status at Baseline
7
On - Treatment Drugs
8
Univariate Analysis Odds ratio of virological
failure
DAF DAC
NRTI sens/10
new drugs
NRTI sens/4
PI sens 4
PI sens/10
sens/10
sens/4
RNA
9
Multivariate Analysis Odds ratio of virological
failure
DAF DAC
Multivariate 2
Multivariate 1
RNA New Drugs Sens/4
RNA New Drugs Sens/10
10
Multivariate Analysis Odds ratio of virological
failure
DAF DAC
Multivariate 4
Multivariate 3
RNA New Drugs NRTI Sens/4
PI Sens/4
RNA New Drugs NRTI Sens/10 PI Sens
10
11
Conclusion
  • in this retrospective analysis based on a small
    group of extensively experienced patients,
    phenotypic resistance was a significant predictor
    of virologic response, independent of baseline
    viral load and previous antiretroviral history
  • either a 4-fold or a 10-fold cut-off provided
    significant independent information
  • in models looking at resistance within individual
    drug classes, resistance to PI was more
    predictive than resistance to NRTI
Write a Comment
User Comments (0)
About PowerShow.com